Summary
In Japan, new antibiotics under development are compared with conventional antibiotics in Phase III controlled studies. Since the patients' demographic data, dosage, treatment period, etc. are made as uniform as possible in these studies, the results obtained are suitable for evaluating the characteristics of the new antibiotics. Most patients developing clinical superinfections suffer from complicated urinary tract infections due to underlying diseases. In order to avoid clinical superinfections, clinicians have to try to eradicate or alleviate these underlying diseases. The predominant microorganisms that may cause clinical superinfections to develop following therapy with broad-spectrum beta-lactam antibiotics include enterococci,Pseudomonas aeruginosa, otherPseudomonas spp. and fungi. Enterococci may frequently be detected in patients with mixed infections and can easily be dealt with by changing the antibiotics.
Zusammenfassung
In kontrollierten Phase III-Studien werden derzeit in Japan neue, in der Entwicklung befindliche Antibiotika verglichen. Da auf eine möglichst weitgehende Übereinstimmung der demographischen Daten der Patienten, der Dosierung und Behandlungsdauer geachtet wurde, können die Ergebnisse der Studien zur Beurteilung der Eigenschaften der neuen Antibiotika herangezogen werden. Die meisten Patienten, bei denen klinische Superinfektionen auftreten, leiden an Krankheiten der Harnwege, auf die sich komplizierte Harnwegsinfektionen aufpfropfen. Die Beseitigung oder Besserung dieser Grundkrankheiten ist die Voraussetzung dafür, daß klinische Superinfektionen vermieden werden können. Unter den Mikroorganismen, die vorwiegend nach Behandlung mit Breitspektrum-Beta-Lactam-Antibiotika klinische Superinfektionen auslösen können, sind Enterokokken,Pseudomonas aeruginosa, Pseudomonas spp. und Pilze. Enterokokken finden sich häufig bei Patienten mit Mischinfektionen, sie sind durch Wechsel der Antibiotika leicht zu beseitigen.
Similar content being viewed by others
Literature
Momose, S., Kumazawa, J., Sakamoto, K., Oshima, K., Eto, K., Miyoshi, N., Kondo, A., Nakano, S., Ikegami, K., Ueda, S., Ishizawa, Y., Senoh, K., Okamoto, K., Ohi, Y., Osawa, A., Ogawa, N., Horioka, M., Kono, M. A double blind controlled study to compare CS-1170 (cefmetazole) and cefazolin in the treatment of chronic complicated urinary tract infections. Nishinihon J. Urol. 41 (1979) 173–200.
Kawada, Y., Muranaka, K., Nishiura, T., Ohi, Y., Okamoto, K., Saito, Y., Ueda, S., Eto, K., Kumazawa, J., Momose, S., Kodama, M., Nihira, H., Akazawa, N., Ohmori, H., Chigusa, I., Tada, S., Ohkawa, M., Hisazumi, H., Kishi, H., Niijima, T., Onodera, S., Machida, T., Ueno, K., Tanaka, T. Comparative studies of T-1982 (cefbuperazone) and cefmetazole in complicated urinary tract infections. J. Jpn. Assoc. Infect. Dis. 57 (1983) 470–486.
Ishigami, J., Kamidono, S., Arakawa, S., Kataoka, N., Nakano, K., Harada, M., Hirooka, K., Shimatani, N., Itani, A., Matsushita, M., Hikosaka, K., Matsumoto, O., Ohya, K., Ito, N., Harada, K., Kiyota T., Takahashi, Y., Hara, S., Ohmae, H., Ohbe, T., Yasuno, H., Kataoka, N., Okudaira, H., Kawabata, G., Ohshima, H., Den, S., Tomioka, O., Tadera, K., Okada, Y., Hineno, S., Kuroda, Y., Momose, S., Takei, M., Kumazawa, J., Nakamuta, S., Sakamoto, K., Oshima, K., Ishizawa, N., Osada, Y., Hara, S., Emoto, K., Hirata, K., Morita, I., Minoda, K., Hirano, H., Nagayoshi, H., Sato, S., Omoyo, T., Yagi, H., Hirata, H., Ando, S., Iwatsubo, E., Komine, S., Ogawa, N. Double-blind comparative clinical study of cefpiramide (SM-1652) and cefmetazole in complicated urinary tract infections. J. Jpn. Assoc. Infect. Dis. 57 (1983) 695–723.
Kumazawa, J., Nakamuta, S., Momose, S., Sakamoto, K., Oshima, K., Ishizawa, N., Senoh, K., Hirata, K., Emoto, K., Aito, K., Hara, S., Yamaguchi, A., Omoto, T., Nagayoshi, H., Hieda, S., Kamizaki, H., Yoshimine, K., Hirata, H. A comparative study of CTX and CTZ in the treatment of complicated urinary tract infections. Nishinihon J. Urol. 42 (1980) 1293–1310.
Shimizu, Y., Kato, N., Tei, H., Nishiura, T., Tsuji, I., Kumamoto, Y., Tsuchida, S., Niijima, T., Saito, T., Iki, Y., Ohkoshi, M., Naide, Y., Obata, K., Yoshida, O., Watanabe, H., Ishigami, J., Momose, S., Tanaka, T., Ueno, K. A comparative study of cefotaxime and sulbenicillin in the treatment of complicated urinary tract infections. Chemotherapy 29 (1981) 107–131.
Kumazawa, J., Iguchi, A., Kumamoto, Y., Sakai, S., Niijima, T., Kishi, H., Machida, T., Kawamura, N., Okada, K., Nishiura, T., Ban, Y., Naide, Y., Watanabe, H., Ishigami, J., Kamidono, S., Omori, H., Tanaka, H., Nihira, H., Kurokawa, K., Fujita, Y., Kondo, K., Ohi, Y., Ogawa, N., Nagayama, A. A comparative study of efficacy of MT-141 and cefotaxime (CTX) in the treatment of complicated urinary tract infections. Nishinihon J. Urol. 46 (1984) 1491–1516.
Ban, Y., Nishiura, T., Okamoto, K., Eto, K., Momose, S., Kurokawa, K., Omori, H., Ishigami, J., Tada, S., Kuroda, K., Ohkoshi, M., Machide, T., Kawano, M., Tanaka, T. Clinical appraisal of cefoperazone (T-1551) in complicated urinary tract infection — Comparative study with carbenicillin. Chemotherapy 28 (S-6) (1980) 947–974.
Kawamura, N., Hihara, T., Miyakita, H., Kawashima, T., Nagata, Y., Katsuoka, Y., Okada, K., Kinoshita, H., Matsushita, K., Ohkoshi, M., Kumamoto, Y., Hirose, T., Enatsu, C., Tsuchida, S., Takada, H., Noto, M., Matsuo, S., Kaneko, H., Tominaga, T., Kishi, H., Niijima, T., Kitamura, T., Nishimura, Y., Saito, Y., Asano, M., Yuge, J., Saito, T., Machida, T., Onodera, S., Suzuki, H., Nagakubo, I., Hoshinaga, K., Matsui, M., Takanashi, K., Yamamoto, Y., Suzuki, K., Hisazumi, H., Ohkawa, M., Hirano, S., Mikawa, I., Naide, Y., Fujita, T., Ogawa, T., Hirabayashi, S., Yanaoka, M., Okishio, N., Ishiguro, K., Moriguchi, R., Kobayashi, K., Ban, Y., Kawada, Y., Nishiura, T., Doi, T., Ishiyama, S., Setsuda, O., Isogai, K., Takeuchi, K., Kanhin, T., Zaitsu, K., Yoshida, O., Higashi, Y., Ishigami, K., Kamidono, S., Arakawa, S., Harada, M., Ohbe, T., Yasuno, H., Ohshima, H., Den, S., Kataoka, N., Okudaira, H., Kawabata, G., Tomioka, O., Yamasaki, H., Ohmori, H., Kumon, H., Kondo, A., Nanba, K., Shiraga, T., Katayama, Y., Akaeda, T., Takamoto, H., Kamata, H., Kume, T., Nihira, H., Kodama, M., Kobukata, Y., Moriyama, H., Kurokawa, K., Fujimura, N., Yuasa, K., Kitada, S., Yoshimine, K., Senoh, K., Eto, K., Ueda, S., Kumazawa, J., Nakamuta, S., Matsuya, F., Shimomae, E., Ohi, Y., Kawabata, T., Goto, T., Kawahara, M., Asechi, S., Sakamoto, N., Nagata, S., Yagi, S., Obata, M., Shimada, T., Ueno, K. A comparative study on ceftazidime and cefoperazone in the treatment of urinary tract infections in double blind manner. J. Jpn. Assoc. Infect. Dis. 58 (1984) 862–893.
Kumazawa, J., Nakamuta, S., Kumamoto, Y., Sakai, S., Tsuchida, M., Orikasa, S., Niijima, T., Kishi, H., Machida, T., Ohkoshi, M., Kawamura, N., Naide, Y., Tada, S., Nishiura, T., Ban, Y., Watanabe, H., Ishigami, J., Kamidono, S., Ohmori, H., Kumon, H., Tanaka, H., Nihira, H., Kurokawa, K., Eto, K., Ikegami, K., Ohi, Y., Nagayama, A., Ogawa, N. Clinical evaluation of AC-1370 in complicated urinary tract infections. A double blind controlled study with cefoperazone. Nishinihon J. Urol. 47 (1985) 237–265.
Ban, Y., Nishiura, T., Kumamoto, Y., Niijima, T., Machida, T., Ohkoshi, M., Kuroda, K., Naide, Y., Ishigami, J., Kurokawa, K., Ohmori, H., Nihira, H., Momose, S., Eto, K., Okamoto, K., Ueno, K., Tanaka, T. Clinical appraisal of oxacephem antibiotic “6059-S” in complicated urinary tract infection — Comparative study with sulbenicillin. Chemotherapy 29 (1981) 533–566.
Ishigami, J., Kamidono, S., Kuroda, T., Kataoka, N., Momose, S., Nakamuta, S., Minoda, K., Kumazawa, J., Miyazaki, S., Ra, S., Sakamoto, K., Oshima, K., Ishizawa, N., Osada, Y., Furusawa, T., Hirooka, K., Shimatani, N., Itani, J., Ito, N., Takahashi, Y., Saito, H., Nakano, K., Ono, S., Tadera, N., Kuroda, K., Oshima, H., Ogawa, T., Mayumi, K., Harada, M., Obe, S., Shida, K., Kataoka, K., Hineno, T., Yasumuro, C., Hara, S., Omae, H., Hirata, K., Morita, I., Emoto, K., Kamizaki, H., Hara, S., Yamaguchi, A., Nagayoshi, H., Hieda, S., Omoto, T., Yagi, H., Sato, S., Komine, S., Kinoshita, N., Hirano, H., Mizunoe, Y., Hirata, H., Kitada, S., Naito, S., Mathuse, K., Akita, Y., Fujisawa, A., Demura, A. Double blind test results of cefmenoxime (SCE-1365) and cefotiam in the treatment of chronic complicated urinary tract infections. Chemotherapy 30 (1982) 724–747.
Ohkoshi, M., Kawamura, N. Criteria for evaluation of clinical efficacy of antimicrobial agents on urinary tract infection. Chemotherapy 28 (1980) 321–341, 1351–1358.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kumazawa, J. Clinical superinfection in complicated urinary tract infections: Therapy with broad-spectrum beta-lactam antibiotics in urology. Infection 13 (Suppl 1), S96–S99 (1985). https://doi.org/10.1007/BF01644227
Issue Date:
DOI: https://doi.org/10.1007/BF01644227